Skip to main content
. 2017 Jun 27;3(2):267–281. doi: 10.1007/s41030-017-0046-2

Fig. 2.

Fig. 2

SABA short-acting β2-agonist, SAMA short-acting antimuscarinic antagonist, LABA long-acting β2-agonist, LAMA short acting antimuscarinic antagonist, ICS inhaled corticosteroid